Lifecore Biomedical Inc. (LFCR) financials · $207.1M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Lifecore Biomedical Inc. (LFCR) $207.1M cap.
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Revenue | $34.2M | $23.2M |
| Cost of Revenue | $22.1M | $18.7M |
| Gross Profit | $12.1M | $4.46M |
| Operating Income | $2.57M | -$4.67M |
| Net Income | -$6.16M | -$15.0M |
| EPS (Diluted) | -$0.19 | -$0.43 |
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Assets | $229.5M | $225.5M |
| Current Assets | $83.7M | $77.6M |
| Cash & Equivalents | $17.2M | $20.8M |
| Inventory | $25.5M | $28.2M |
| PP&E | $123.7M | $125.5M |
| Total Liabilities | $213.4M | $204.7M |
| Current Liabilities | $21.6M | $20.5M |
| Short-term Debt | $970.0K | $962.0K |
| Long-term Debt | $155.1M | $148.7M |
| Total Debt | $156.0M† | $149.7M† |
| Shareholders' Equity | -$34.1M | -$28.4M |
| Retained Earnings | -$244.3M | -$238.2M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $7.33M | -$217.0K |
| CapEx | $3.70M | $18.4M |
| Investing Cash Flow | $6.30M | -$17.9M |
| Financing Cash Flow | -$4.43M | $7.51M |
| Net Change in Cash | $9.20M | -$10.6M |
| Free Cash Flow | $3.63M | -$18.6M |
FAQ
What is LFCR P/E and revenue?
Lifecore Biomedical Inc. (LFCR) $207.1M cap.
What is LFCR revenue?
Lifecore Biomedical Inc. last cached revenue is $34.2M (Q2 2026).
Is LFCR profitable?
Lifecore Biomedical Inc. last cached net income is -$6.16M (Q2 2026).
What are LFCR total assets?
Lifecore Biomedical Inc. last cached total assets are $229.5M (Q2 2026).
What is LFCR free cash flow?
Lifecore Biomedical Inc. last cached free cash flow is $3.63M (FY2025).
Not investment advice. Cached statements, not a live tape.